Rocket Lab shares slide as $1B at-the-market equity program revives dilution concerns

Rocket Lab Corporation (RKLB) is down 4.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is investor concern about potential dilution after the company filed for a new at-the-market (ATM) equity program that can sell up to $1.0 billion of common stock over time. Even though the company has also posted recent operational wins, the financing overhang can pressure the stock in the near term as traders anticipate incremental share supply.

Details:

On March 17, 2026, Rocket Lab entered an equity distribution agreement that allows it to offer and sell up to $1,000,000,000 of common stock through multiple sales agents.

The filing describes the use of forward sale structures where counterparties may borrow and sell shares to hedge, with Rocket Lab later settling in cash or stock, which can create additional supply/dilution uncertainty.

In the related prospectus supplement, Rocket Lab disclosed it had sold about $749.4 million under its prior $750 million program and is terminating that prior sales agreement as it transitions to the new framework.

Rocket Lab also recently announced a $190 million block-buy launch deal for 20 hypersonic test flights using its HASTE vehicle, but the financing headline may be outweighing that positive news in today’s tape.

Sources:

SEC EDGAR, Space.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$RKLB Insider Trading Activity

$RKLB insiders have traded $RKLB stock on the open market 116 times in the past 6 months. Of those trades, 0 have been purchases and 116 have been sales.

Here’s a breakdown of recent trading of $RKLB stock by insiders over the last 6 months:

PETER BECK (CEO) has made 0 purchases and 22 sales selling 2,537,714 shares for an estimated $143,184,322.
ADAM C. SPICE (Chief Financial Officer) has made 0 purchases and 15 sales selling 1,491,036 shares for an estimated $110,024,523.
FRANK KLEIN (Chief Operations Officer) has made 0 purchases and 24 sales selling 227,768 shares for an estimated $14,933,740.
MERLINE SAINTIL has made 0 purchases and 10 sales selling 161,626 shares for an estimated $12,849,172.
ARJUN KAMPANI (SVP & General Counsel) has made 0 purchases and 15 sales selling 91,641 shares for an estimated $5,314,769.
JON A OLSON has made 0 purchases and 20 sales selling 90,605 shares for an estimated $5,130,467.
NINA ARMAGNO has made 0 purchases and 9 sales selling 27,314 shares for an estimated $1,862,972.
EDWARD H. FRANK sold 2,500 shares for an estimated $193,471

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RKLB Hedge Fund Activity

We have seen 502 institutional investors add shares of $RKLB stock to their portfolio, and 330 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

VK SERVICES, LLC removed 8,323,617 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $580,655,521
BAILLIE GIFFORD & CO added 5,725,536 shares (+47.2%) to their portfolio in Q4 2025, for an estimated $399,413,391
VANGUARD GROUP INC added 5,610,469 shares (+13.4%) to their portfolio in Q4 2025, for an estimated $391,386,317
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,403,335 shares (-72.1%) from their portfolio in Q4 2025, for an estimated $307,176,649
JPMORGAN CHASE & CO added 4,122,175 shares (+74.0%) to their portfolio in Q4 2025, for an estimated $287,562,928
TIDAL INVESTMENTS LLC removed 3,749,041 shares (-97.3%) from their portfolio in Q4 2025, for an estimated $261,533,100
MORGAN STANLEY removed 2,929,182 shares (-41.1%) from their portfolio in Q4 2025, for an estimated $204,339,736

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$RKLB Government Contracts

We have seen $14,384,938 of award payments to $RKLB over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$RKLB Analyst Ratings

Wall Street analysts have issued reports on $RKLB in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

B of A Securities issued a "Buy" rating on 01/20/2026
Morgan Stanley issued a "Overweight" rating on 01/16/2026
Needham issued a "Buy" rating on 12/23/2025

To track analyst ratings and price targets for $RKLB, check out Quiver Quantitative's $RKLB forecast page.

$RKLB Price Targets

Multiple analysts have issued price targets for $RKLB recently. We have seen 9 analysts offer price targets for $RKLB in the last 6 months, with a median target of $85.0.

Here are some recent targets:

Greg Pendy from Clear Street set a target price of $88.0 on 03/19/2026
Andres Sheppard from Cantor Fitzgerald set a target price of $85.0 on 03/13/2026
Ryan Koontz from Needham set a target price of $95.0 on 02/27/2026
Anthony Valentini from Goldman Sachs set a target price of $69.0 on 01/20/2026
Ronald Epstein from B of A Securities set a target price of $120.0 on 01/20/2026
Kristine Liwag from Morgan Stanley set a target price of $105.0 on 01/16/2026
Erik Rasmussen from Stifel set a target price of $85.0 on 12/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.